NPIC
SUPN icon

Neumeier Poma Investment Counsel’s Supernus Pharmaceuticals SUPN Stock Holding History

Neumeier Poma Investment Counsel’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-550,676
Closed -$15.1M – 44
2019
Q3 		$15.1M Sell
550,676
-406,725
-42% -$12.1M 1.26% 34
2019
Q2 		$31.7M Buy
957,401
+10,170
+1% +$348K 2.62% 16
2019
Q1 		$33.2M Buy
947,231
+452,900
+92% +$16.9M 2.79% 16
2018
Q4 		$16.4M Buy
494,331
+23,071
+5% +$992K 1.56% 31
2018
Q3 		$23.7M Buy
471,260
+45,010
+11% +$2.22M 1.96% 23
2018
Q2 		$25.5M Sell
426,250
-97,100
-19% -$5.03M 2.37% 19
2018
Q1 		$24M Buy
523,350
+855
+0.2% +$35.7K 2.47% 15
2017
Q4 		$20.8M Sell
522,495
-198,925
-28% -$7.86M 2.09% 25
2017
Q3 		$28.9M Sell
721,420
-169,320
-19% -$7.33M 3.02% 13
2017
Q2 		$38.4M Buy
890,740
+14,430
+2% +$514K 4.47% 3
2017
Q1 		$27.4M Buy
876,310
+97,610
+13% +$2.62M 3.28% 10
2016
Q4 		$19.7M Sell
778,700
-244,240
-24% -$5.46M 2.71% 20
2016
Q3 		$25.3M Sell
1,022,940
-190,615
-16% -$4.31M 3.79% 4
2016
Q2 		$24.7M Buy
1,213,555
+9,625
+0.8% +$171K 3.91% 5
2016
Q1 		$18.4M Buy
1,203,930
+302,600
+34% +$3.95M 2.91% 14
2015
Q4 		$12.1M Buy
+901,330
New +$13.9M 2.09% 27

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Neumeier Poma Investment Counsel's SUPN Position: Q4 2019 in Review

Neumeier Poma Investment Counsel sold out of Supernus Pharmaceuticals (SUPN) in Q4 2019, closing a stake of 550,676 shares — an estimated $15.1M sold.

Neumeier Poma Investment Counsel first reported a position in SUPN in Q4 2015 and held it in 16 quarters. The position peaked at $38.4M in Q2 2017. 235 funds tracked by Wall St. Rank hold SUPN as of Q4 2019.

  • Neumeier Poma Investment Counsel reported no remaining Supernus Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Neumeier Poma Investment Counsel sold 550,676 Supernus Pharmaceuticals shares in Q4 2019, an estimated $15.1M.
  • Neumeier Poma Investment Counsel first reported a position in Supernus Pharmaceuticals in Q4 2015 and held it in 16 quarters.
  • Neumeier Poma Investment Counsel's Supernus Pharmaceuticals position peaked at $38.4M in Q2 2017.
  • 235 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2019.

Based on Neumeier Poma Investment Counsel's 13F filing for Q4 2019, filed 12 Feb 2020.